Pomerantz has moved the court to approve a $17.75 million settlement in its investor suit against Ginkgo Bioworks, a #biotech company alleged to have misled investors about the extent to which its revenue came from related-party deals, prior to going public via a #SPAC merger.
0
0
0
202
0
Download Image